$TWST
Twist Bioscience Corp

2021 Q4 Form 10-Q Financial Statement

#000110465922017090 Filed on February 09, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4
Revenue $42.02M $28.16M
YoY Change 49.21% 64.07%
Cost Of Revenue $27.06M $18.16M
YoY Change 48.97% 31.69%
Gross Profit $14.96M $9.999M
YoY Change 49.63% 196.53%
Gross Profit Margin 35.61% 35.51%
Selling, General & Admin $51.10M $28.79M
YoY Change 77.47% 9.04%
% of Gross Profit 341.52% 287.95%
Research & Development $22.63M $14.00M
YoY Change 61.64% 35.96%
% of Gross Profit 151.25% 140.01%
Depreciation & Amortization $3.150M $2.111M
YoY Change 49.22% 40.27%
% of Gross Profit 21.05% 21.11%
Operating Expenses $73.73M $42.79M
YoY Change 72.29% 16.59%
Operating Profit -$55.94M -$32.79M
YoY Change 70.59% -41.26%
Interest Expense $26.00K $118.0K
YoY Change -77.97% -52.42%
% of Operating Profit
Other Income/Expense, Net -$156.0K -$77.00K
YoY Change 102.6% -11.49%
Pretax Income -$55.97M -$32.85M
YoY Change 70.35% -40.91%
Income Tax -$10.41M $46.00K
% Of Pretax Income
Net Earnings -$45.56M -$32.90M
YoY Change 38.49% -40.87%
Net Earnings / Revenue -108.44% -116.83%
Basic Earnings Per Share -$0.91
Diluted Earnings Per Share -$912.9K -$715.2K
COMMON SHARES
Basic Shares Outstanding 49.63M 45.15M
Diluted Shares Outstanding 49.91M shares

Balance Sheet

Concept 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $301.9M $587.3M
YoY Change -48.6% 469.64%
Cash & Equivalents $191.6M $350.3M
Short-Term Investments $110.2M $238.5M
Other Short-Term Assets $10.04M $8.200M
YoY Change 22.4% 43.86%
Inventory $40.24M $13.40M
Prepaid Expenses
Receivables $32.87M $23.20M
Other Receivables $5.834M $2.300M
Total Short-Term Assets $385.0M $634.4M
YoY Change -39.31% 390.69%
LONG-TERM ASSETS
Property, Plant & Equipment $65.14M $59.50M
YoY Change 9.47% 178.83%
Goodwill $84.24M
YoY Change
Intangibles
YoY Change
Long-Term Investments $106.8M
YoY Change
Other Assets $7.425M $4.300M
YoY Change 72.67% 92.22%
Total Long-Term Assets $401.2M $65.20M
YoY Change 515.28% 3.51%
TOTAL ASSETS
Total Short-Term Assets $385.0M $634.4M
Total Long-Term Assets $401.2M $65.20M
Total Assets $786.2M $699.6M
YoY Change 12.37% 263.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.07M $8.900M
YoY Change 159.25% -2.26%
Accrued Expenses $11.69M $21.50M
YoY Change -45.65% 358.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $3.300M
YoY Change -100.0% -0.99%
Total Short-Term Liabilities $80.03M $37.10M
YoY Change 115.73% -35.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $600.0K
YoY Change -100.0% -83.65%
Other Long-Term Liabilities $19.67M $23.90M
YoY Change -17.7% 16497.22%
Total Long-Term Liabilities $19.67M $24.50M
YoY Change -19.71% 542.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $80.03M $37.10M
Total Long-Term Liabilities $19.67M $24.50M
Total Liabilities $160.0M $61.60M
YoY Change 159.72% -30.94%
SHAREHOLDERS EQUITY
Retained Earnings -$656.1M
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $626.2M $638.0M
YoY Change
Total Liabilities & Shareholders Equity $786.2M $699.6M
YoY Change 12.37% 263.85%

Cashflow Statement

Concept 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income -$45.56M -$32.90M
YoY Change 38.49% -40.87%
Depreciation, Depletion And Amortization $3.150M $2.111M
YoY Change 49.22% 40.27%
Cash From Operating Activities -$46.65M -$24.93M
YoY Change 87.12% -28.59%
INVESTING ACTIVITIES
Capital Expenditures $12.78M $3.629M
YoY Change 252.25% 76.34%
Acquisitions $8.160M
YoY Change
Other Investing Activities -$213.8M -$42.29M
YoY Change 405.55% -392.46%
Cash From Investing Activities -$226.6M -$45.92M
YoY Change 393.42% -470.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.011M 326.9M
YoY Change -100.31% 15793.1%
NET CHANGE
Cash From Operating Activities -46.65M -24.93M
Cash From Investing Activities -226.6M -45.92M
Cash From Financing Activities -1.011M 326.9M
Net Change In Cash -274.2M 256.1M
YoY Change -207.06% -1352.62%
FREE CASH FLOW
Cash From Operating Activities -$46.65M -$24.93M
Capital Expenditures $12.78M $3.629M
Free Cash Flow -$59.44M -$28.56M
YoY Change 108.1% -22.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50735000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49499000
CY2021Q4 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001581280
CY2021Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2021Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q4 dei Document Type
DocumentType
10-Q
CY2021Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q4 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q4 dei Entity File Number
EntityFileNumber
001-38720
CY2021Q4 dei Entity Registrant Name
EntityRegistrantName
Twist Bioscience Corporation
CY2021Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2058888
CY2021Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
681 Gateway Blvd
CY2021Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
CY2021Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
CY2021Q4 dei City Area Code
CityAreaCode
800
CY2021Q4 dei Local Phone Number
LocalPhoneNumber
719-0671
CY2021Q4 dei Security12b Title
Security12bTitle
Common Stock
CY2021Q4 dei Trading Symbol
TradingSymbol
TWST
CY2021Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50885068
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191624000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465829000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
110235000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
12034000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32872000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28549000
CY2021Q4 us-gaap Inventory Net
InventoryNet
40239000
CY2021Q3 us-gaap Inventory Net
InventoryNet
31800000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50735000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
363000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10037000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8283000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
385007000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
546495000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
106843000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65135000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44122000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
72020000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61580000
CY2021Q4 us-gaap Goodwill
Goodwill
84244000
CY2021Q3 us-gaap Goodwill
Goodwill
22434000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
63921000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18262000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1572000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1530000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7425000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7674000
CY2021Q4 us-gaap Assets
Assets
786167000
CY2021Q3 us-gaap Assets
Assets
702097000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23073000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
14900000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11686000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6437000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18735000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22327000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12684000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8213000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1552000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13856000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9623000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
80034000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
63052000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60285000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53156000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19670000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5068000
CY2021Q4 us-gaap Liabilities
Liabilities
159989000
CY2021Q3 us-gaap Liabilities
Liabilities
121276000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49499000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1281931000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1190828000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10405000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
546000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-656116000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-610553000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
626178000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
580821000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
786167000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
702097000
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42018000
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28161000
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
27056000
CY2020Q4 us-gaap Cost Of Revenue
CostOfRevenue
18162000
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22630000
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14000000
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51098000
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28792000
CY2021Q4 twst Change In Fair Value Of Contingent Consideration And Indemnity Holdback
ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback
2826000
CY2020Q4 twst Change In Fair Value Of Contingent Consideration And Indemnity Holdback
ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback
0
CY2021Q4 us-gaap Costs And Expenses
CostsAndExpenses
97958000
CY2020Q4 us-gaap Costs And Expenses
CostsAndExpenses
60954000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-55940000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-32793000
CY2021Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
154000
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
134000
CY2021Q4 us-gaap Interest Expense
InterestExpense
26000
CY2020Q4 us-gaap Interest Expense
InterestExpense
118000
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-156000
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-77000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55968000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32854000
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-45563000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32900000
CY2021Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
277000
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8000
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-94000
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
63000
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45380000
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32845000
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.91
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
CY2021Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
49912000
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46000000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
580821000
CY2021Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
72514000
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3039000
CY2021Q4 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-2558000
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18108000
CY2020Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-884000
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-183000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-45563000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
626178000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
336262000
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
323851000
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6072000
CY2020Q4 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-2410000
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7022000
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
55000
CY2020Q4 us-gaap Profit Loss
ProfitLoss
-32900000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
637952000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-45563000
CY2020Q4 us-gaap Profit Loss
ProfitLoss
-32900000
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3150000
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2111000
CY2021Q4 twst Business Acquisition Income Tax Benefit Due To Deferred Tax Liability
BusinessAcquisitionIncomeTaxBenefitDueToDeferredTaxLiability
10545000
CY2020Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
CY2021Q4 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
1174000
CY2020Q4 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
248000
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
18108000
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
7022000
CY2021Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-318000
CY2020Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-122000
CY2021Q4 twst Change In Fair Value Of Contingent Consideration And Indemnity Holdback
ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback
2826000
CY2021Q4 us-gaap Other Noncash Expense
OtherNoncashExpense
3000
CY2020Q4 us-gaap Other Noncash Expense
OtherNoncashExpense
25000
CY2021Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4000
CY2020Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
30000
CY2021Q4 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-70000
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2032000
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8436000
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1122000
CY2021Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
91000
CY2020Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2043000
CY2021Q4 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3231000
CY2020Q4 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-59000
CY2021Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5000
CY2020Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3459000
CY2021Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
445000
CY2020Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-149000
CY2021Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3624000
CY2020Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3357000
CY2021Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-34000
CY2020Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
677000
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46653000
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24932000
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12783000
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3629000
CY2021Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8160000
CY2021Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
217639000
CY2020Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
74292000
CY2021Q4 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
12000000
CY2020Q4 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
32000000
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-226582000
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45921000
CY2021Q4 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3105000
CY2020Q4 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6084000
CY2020Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
324080000
CY2021Q4 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-1558000
CY2020Q4 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-833000
CY2021Q4 twst Payments To Repurchases Of Common Stock For Tax Withholding
PaymentsToRepurchasesOfCommonStockForTaxWithholding
2558000
CY2020Q4 twst Payments To Repurchases Of Common Stock For Tax Withholding
PaymentsToRepurchasesOfCommonStockForTaxWithholding
2410000
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1011000
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
326921000
CY2021Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83000
CY2020Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-274163000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
256073000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
467359000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94246000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193196000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
350319000
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
9000
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
61000
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
91000
CY2020Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
81000
CY2021Q4 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
11479000
CY2020Q4 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1515000
CY2021Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10423000
CY2020Q4 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
229000
CY2021Q4 us-gaap Stock Issued1
StockIssued1
72514000
CY2020Q4 us-gaap Stock Issued1
StockIssued1
0
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-656100000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191624000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465829000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1572000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1530000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193196000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
467359000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
360093000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
28368000
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
442472000
CY2021Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
9856000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
8500000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-700000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7800000
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1900000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
27375000
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
26549000
CY2021Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
5834000
CY2021Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
2337000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
337000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
337000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32872000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28549000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
30336000
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
18778000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3143000
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
4837000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6760000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8185000
CY2021Q4 us-gaap Inventory Net
InventoryNet
40239000
CY2021Q3 us-gaap Inventory Net
InventoryNet
31800000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1400000
CY2021Q4 twst Convertible Note Receivable
ConvertibleNoteReceivable
3051000
CY2021Q3 twst Convertible Note Receivable
ConvertibleNoteReceivable
3021000
CY2021Q4 twst Other Assets Noncurrent Excluding Convertible Receivable
OtherAssetsNoncurrentExcludingConvertibleReceivable
4374000
CY2021Q3 twst Other Assets Noncurrent Excluding Convertible Receivable
OtherAssetsNoncurrentExcludingConvertibleReceivable
4653000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7425000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7674000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
8796000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5057000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2890000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1380000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11686000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6437000
CY2021Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
5227000
CY2021Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
4643000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2858000
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
8584000
CY2021Q4 twst Accrued Commissions Current
AccruedCommissionsCurrent
2520000
CY2021Q3 twst Accrued Commissions Current
AccruedCommissionsCurrent
3330000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
5603000
CY2021Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4676000
CY2021Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
2527000
CY2021Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1094000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18735000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22327000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
19286000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
4671000
CY2021Q4 twst Other Liabilities Non Current Other Than Contingent Consideration
OtherLiabilitiesNonCurrentOtherThanContingentConsideration
384000
CY2021Q3 twst Other Liabilities Non Current Other Than Contingent Consideration
OtherLiabilitiesNonCurrentOtherThanContingentConsideration
397000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19670000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5068000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
66130000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2209000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
63921000
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19630000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1368000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18262000
CY2021Q4 us-gaap Lessor Operating Lease Existence Of Option To Extend
LessorOperatingLeaseExistenceOfOptionToExtend
true
CY2021Q4 us-gaap Lessor Operating Lease Existence Of Option To Terminate
LessorOperatingLeaseExistenceOfOptionToTerminate
true
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
72020000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12684000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12684000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60285000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60285000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9474000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
13203000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12275000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12487000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11012000
CY2021Q4 twst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
88764000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
147215000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
56618000
CY2021Q4 us-gaap Lease Incentive Receivable
LeaseIncentiveReceivable
17628000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
72969000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12684000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60285000
CY2021Q4 us-gaap Lease Incentive Receivable
LeaseIncentiveReceivable
17600000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9500000
CY2021Q4 twst Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
10400000
CY2021Q4 twst Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
11600000
CY2020Q4 twst Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
1400000
CY2020Q4 twst Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
1100000
CY2021Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
3500000
CY2020Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
1900000
CY2021Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
2900000
CY2020Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
1700000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y11M19D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0639
CY2021Q3 twst Lessee Operating Lease Area
LesseeOperatingLeaseArea
21000
CY2021Q4 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
1700000
CY2020Q4 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
1100000
CY2021Q4 twst Business Acquisition Income Tax Benefit Due To Deferred Tax Liability
BusinessAcquisitionIncomeTaxBenefitDueToDeferredTaxLiability
10500000
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
26385
CY2020Q4 twst Stock Warrants Exercised
StockWarrantsExercised
18854
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
14.85
CY2020Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
16051
CY2020Q4 twst Stock Warrants Exercised
StockWarrantsExercised
7531
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
21.24
CY2020Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
6041
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18068000
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7022000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
25300000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
83.07
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
355000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
250000
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
605000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-45563000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32900000
CY2021Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
49912000
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46000000
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.91
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4583000
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4443000
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42018000
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28161000
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42018000
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28161000
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42018000
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28161000

Files In Submission

Name View Source Status
0001104659-22-017090-index-headers.html Edgar Link pending
0001104659-22-017090-index.html Edgar Link pending
0001104659-22-017090.txt Edgar Link pending
0001104659-22-017090-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twst-20211231.xsd Edgar Link pending
twst-20211231x10q.htm Edgar Link pending
twst-20211231x10q004.jpg Edgar Link pending
twst-20211231x10q_htm.xml Edgar Link completed
twst-20211231xex31d1.htm Edgar Link pending
twst-20211231xex31d2.htm Edgar Link pending
twst-20211231xex32d1.htm Edgar Link pending
twst-20211231xex32d2.htm Edgar Link pending
twst-20211231_cal.xml Edgar Link unprocessable
twst-20211231_def.xml Edgar Link unprocessable
twst-20211231_lab.xml Edgar Link unprocessable
twst-20211231_pre.xml Edgar Link unprocessable